Graypoint LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Graypoint LLC

$1.41 Billion
Q2 2024

A detailed history of Graypoint LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Graypoint LLC holds 2,592 shares of XBI stock, worth $255,078. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,592

Previous 2,570 0.86%

Holding current value

$255,078

Previous $243,000 1.23%

% of portfolio

0.02%

Previous 0.02%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$82.22 - $94.12 $1,808 - $2,070	22 Added 0.86%	2,592 $240,000
Q1 2024 May 02, 2024	BUY	$87.05 - $102.89 $223,718 - $264,427	2,570 New	2,570 $243,000
Q2 2023 Jul 21, 2023	BUY	$75.38 - $90.23 $10,703 - $12,812	142 Added 4.12%	3,589 $298,000
Q1 2023 May 02, 2023	BUY	$73.13 - $91.97 $16,893 - $21,245	231 Added 7.18%	3,447 $262,000
Q4 2022 Jan 31, 2023	BUY	$76.72 - $85.66 $6,060 - $6,767	79 Added 2.52%	3,216 $266,000
Q3 2022 Oct 31, 2022	BUY	$75.06 - $94.9 $4,353 - $5,504	58 Added 1.88%	3,137 $249,000
Q2 2022 Aug 01, 2022	SELL	$62.81 - $96.09 $6,281 - $9,609	-100 Reduced 3.15%	3,079 $229,000
Q1 2022 Apr 19, 2022	BUY	$81.07 - $115.44 $257,721 - $366,983	3,179 New	3,179 $286,000

Others Institutions Holding XBI

# of Institutions

893

Shares Held

94.5M

Call Options Held

18.4M

Put Options Held

31.6M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account